Annexon News

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

Additional data from the Phase 2 ARCHER trial demonstrating protection of visual acuity and anatomical structure following ANX007 treatment will be featured as an oral presentation New preclinical dat

GlobeNewswireMay 1 08:00 ET

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., April 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating

GlobeNewswireApr 16 16:05 ET

Express News | Turnstone Biologics Appoints William Waddill to Its Board of Directors

Moomoo 24/7Apr 16 09:00 ET

10 Buy-Rated Stocks With Latest Insider Purchases

Yahoo FinanceApr 14 12:52 ET

Express News | Needham Reiterates Buy on Annexon, Maintains $16 Price Target

Moomoo 24/7Apr 11 07:17 ET

Buy Rating on Annexon Biosciences: Promising Pipeline and Strategic Growth Potential

TipRanksApr 11 06:35 ET

Annexon(ANNX.US) Director Buys US$19,411.2 in Common Stock

$Annexon(ANNX.US)$ Director Carson William H. purchased 3,200 shares of common stock on Apr 8, 2024 at an average price of $6.066 for a total value of $19,411.2.Source: Announcement What is statement

moomoo NewsApr 10 19:57 ET

Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know

Yahoo FinanceApr 10 18:15 ET

10 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaApr 9 13:35 ET

Annexon Insider Ups Holding During Year

Insiders were net buyers of Annexon, Inc.'s (NASDAQ:ANNX ) stock during the past year. That is, insiders bought more stock than they sold. While insider transactions are not the most important thin

Simply Wall StApr 9 08:24 ET

Annexon Inc Entered Sales Agreement Relating To Sale Of Shares Of Common Stock, May Offer Shares Of Common Stock, From Time To Time, For $100M

Annexon Inc Entered Sales Agreement Relating To Sale Of Shares Of Common Stock, May Offer Shares Of Common Stock, From Time To Time, For $100M

BenzingaApr 5 16:13 ET

MGNX, SBNY and SLP Are Among After Hour Movers

Seeking AlphaApr 3 17:24 ET

Express News | Cantor Fitzgerald Reiterates Overweight on Annexon

Moomoo 24/7Apr 3 09:33 ET

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

BRISBANE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with deva

GlobeNewswireApr 3 08:00 ET

Annexon Price Target Maintained With a $12.00/Share by Wells Fargo

Annexon Price Target Maintained With a $12.00/Share by Wells Fargo

Dow JonesApr 1 12:06 ET

What Makes Annexon (ANNX) a New Buy Stock

Yahoo FinanceApr 1 12:00 ET

Annexon Is Maintained at Overweight by JP Morgan

Annexon Is Maintained at Overweight by JP Morgan

Dow JonesApr 1 10:04 ET

Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's Is How to Trade

Yahoo FinanceApr 1 09:55 ET

Express News | JP Morgan Maintains Overweight on Annexon, Raises Price Target to $13

Moomoo 24/7Apr 1 09:53 ET

Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)

TipRanksApr 1 06:03 ET